Moore Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-750,000
| Closed | -$7.7M | – | 595 |
|
|
2023
Q2 | $7.7M | Hold |
750,000
| – | – | 0.13% | 106 |
|
|
2023
Q1 | $7.59M | Hold |
750,000
| – | – | 0.16% | 95 |
|
|
2022
Q4 | $7.5M | Hold |
750,000
| – | – | 0.18% | 98 |
|
|
2022
Q3 | $7.27M | Hold |
750,000
| – | – | 0.17% | 116 |
|
|
2022
Q2 | $7.27M | Hold |
750,000
| – | – | 0.19% | 107 |
|
|
2022
Q1 | $7.31M | Hold |
750,000
| – | – | 0.19% | 116 |
|
|
2021
Q4 | $7.36M | Hold |
750,000
| – | – | 0.15% | 136 |
|
|
2021
Q3 | $7.37M | Buy |
+750,000
| New | +$7.37M | 0.11% | 163 |
|